Table 1.
Characteristics of study population (n = 573).
| Quantitative Variables | Mean | Standard Deviation |
| Age (years) | 73.1 | 5.5 |
| Lawton (IADL) | 6.6 | 1.8 |
| BMI (Kg/m2) | 30.2 | 5.1 |
| Number of comorbidities | 7.8 | 3.3 |
| Number of drugs per patient | 6.8 | 4.0 |
| Number of PIMs per patient | 2.1 | 2.2 |
| Qualitative Variables | Subjects | Percentage |
| Gender | ||
| Male | 245 | 42.8 |
| Female | 328 | 57.2 |
| Living Arrangements | ||
| Living alone | 121 | 21.1 |
| Accompanied living | 452 | 78.9 |
| Frailty | ||
| Robust | 124 | 21.6 |
| Pre-frail | 312 | 54.5 |
| Frail | 137 | 23.9 |
| Most Frequent Comorbidities | ||
| Bone and joint disorders | 431 | 75.2 |
| Hypertension | 404 | 70.5 |
| Dyslipidaemia | 292 | 51.0 |
| Insomnia | 254 | 44.3 |
| Gastrointestinal disease | 241 | 42.0 |
| Peripheral vascular disease | 227 | 39.6 |
| Psychopathology | 207 | 36.1 |
| Diabetes mellitus | 172 | 30.0 |
| Heart disease | 139 | 24.3 |
| Respiratory Disease | 123 | 21.5 |
| Polymedication | 390 | 68.0 |
| PIM prevalence | 383 | 66.8 |
IADL: Instrumental Activities of Daily Living; BMI: Body Mass Index; PIM: Potentially Inappropriate Medication (according to STOPP v2 criteria).